Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,786
archived clinical trials in
Dermatology

Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
1444
mi
from
Boston, MA
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Boston University Medical School
1444
mi
from
Boston, MA
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
1443
mi
from
Boston, MA
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Tufts Medical Center
1443
mi
from
Boston, MA
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
808
mi
from
Ann Arbor, MI
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
University of Michigan-Scleroderma Program
808
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
552
mi
from
Minneapolis, MN
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Univ of Minnesota
552
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
1263
mi
from
New Brunswick, NJ
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
University Medicine and Dentistry of New Jersey
1263
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
1308
mi
from
Albany, NY
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Center for Rheumatology
1308
mi
from
Albany, NY
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
1303
mi
from
New Hyde Park, NY
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
North Shore Long Island Jewish Medical Center
1303
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
1289
mi
from
New York, NY
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Cornell University
1289
mi
from
New York, NY
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
1289
mi
from
New York, NY
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Hospital for Special Surgery
1289
mi
from
New York, NY
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
1223
mi
from
Philadelphia, PA
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Univ of Pennsylvania
1223
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
973
mi
from
Pittsburgh, PA
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
University of Pittsburgh
973
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
1063
mi
from
Charleston, SC
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Medical University of South Carolina
1063
mi
from
Charleston, SC
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
777
mi
from
Salt Lake City, UT
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
University of Utah
777
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
636
mi
from
Milwaukee, WI
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Medical College of Wisconsin
636
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
611
mi
from
Chicago, IL
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Northwestern University
611
mi
from
Chicago, IL
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
1406
mi
from
Worcester, MA
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
University of Massachussetts Memorial Medical Center
1406
mi
from
Worcester, MA
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
552
mi
from
Minneapolis, MN
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
Hennepin County Medical Center
552
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated:  5/2/2016
572
mi
from
Houston, TX
Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients
The Natural History and Outcome of Patients With Scleroderma at High Risk for or With Early Pulmonary Hypertension
Status: Enrolling
Updated: 5/2/2016
University of Texas Health Science Center
572
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
848
mi
from
Phoenix, AZ
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
Arizona Research Center
848
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
1185
mi
from
Bakersfield, CA
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
Bakersfield Dermatology and Skin Cancer Medical Group
1185
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
1178
mi
from
Los Angeles, CA
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
Dermatology Research Associates
1178
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
1078
mi
from
Ocala, FL
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
Renstar Medical Research
1078
mi
from
Ocala, FL
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
798
mi
from
Atlanta, GA
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
Advanced Medical Research, Inc.
798
mi
from
Atlanta, GA
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
803
mi
from
Atlanta, GA
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
The Emory Clinic
803
mi
from
Atlanta, GA
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
611
mi
from
Chicago, IL
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
Northwestern University, Northwestern Medical Faculty Foundation
611
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
612
mi
from
Lake Forest, IL
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
Northwestern Medicine Lake Forest Hospital
612
mi
from
Lake Forest, IL
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
657
mi
from
Louisville, KY
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
Dermatology Specialists PSC
657
mi
from
Louisville, KY
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
1393
mi
from
Lebanon, NH
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
Dartmouth Hitchcock Medical Center
1393
mi
from
Lebanon, NH
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
1289
mi
from
New York, NY
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
Mount Sinai Hospital
1289
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
1286
mi
from
New York, NY
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
NYU Department of Dermatology
1286
mi
from
New York, NY
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
976
mi
from
Winston-Salem, NC
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
PMG Research of Winston-Salem
976
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
1383
mi
from
Portland, OR
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
Oregon Health and Science University
1383
mi
from
Portland, OR
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
1181
mi
from
Norfolk, VA
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
Virginia Clinical Research, Inc.
1181
mi
from
Norfolk, VA
Click here to add this to my saved trials
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated:  5/3/2016
1468
mi
from
Surrey,
Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, EFFICACY AND SAFETY STUDY OF APREMILAST (CC-10004) IN SUBJECTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
Status: Enrolling
Updated: 5/3/2016
Chih-Ho Hong Medical, Inc.
1468
mi
from
Surrey,
Click here to add this to my saved trials
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated:  5/4/2016
1208
mi
from
Camarillo, CA
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated: 5/4/2016
NVISION Camarillo
1208
mi
from
Camarillo, CA
Click here to add this to my saved trials
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated:  5/4/2016
1272
mi
from
Citrus Heights, CA
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated: 5/4/2016
NVISION Sacramento
1272
mi
from
Citrus Heights, CA
Click here to add this to my saved trials
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated:  5/4/2016
1153
mi
from
Fullerton, CA
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated: 5/4/2016
NVISION Fullerton
1153
mi
from
Fullerton, CA
Click here to add this to my saved trials
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated:  5/4/2016
1149
mi
from
Laguna Hills, CA
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated: 5/4/2016
NVISION Laguna Hills
1149
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated:  5/4/2016
1161
mi
from
Newport Beach, CA
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated: 5/4/2016
NVISION Newport Beach
1161
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated:  5/4/2016
1136
mi
from
Ontario, CA
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated: 5/4/2016
NVISION Ontario
1136
mi
from
Ontario, CA
Click here to add this to my saved trials
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated:  5/4/2016
1142
mi
from
San Diego, CA
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated: 5/4/2016
NVISION La Jolla
1142
mi
from
San Diego, CA
Click here to add this to my saved trials
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated:  5/4/2016
1177
mi
from
Sherman Oaks, CA
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated: 5/4/2016
Berg Feinfield Vision Center
1177
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated:  5/4/2016
1178
mi
from
Torrance, CA
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated: 5/4/2016
NVISION Torrance
1178
mi
from
Torrance, CA
Click here to add this to my saved trials
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated:  5/4/2016
960
mi
from
Las Vegas, NV
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated: 5/4/2016
NVISION Las Vegas
960
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated:  5/4/2016
1389
mi
from
Beaverton, OR
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.
Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking at an Irrandiance of 18 mW/cm2 in Eyes With Keratoconus or Ectasia.
Status: Enrolling
Updated: 5/4/2016
Teplick Custom Vision
1389
mi
from
Beaverton, OR
Click here to add this to my saved trials
Pediatric Atopic Dermatitis (AD) Internet Survey
Using an Internet Survey to Improve Adherence in Pediatric Atopic Dermatitis
Status: Enrolling
Updated:  5/5/2016
979
mi
from
Winston-Salem, NC
Pediatric Atopic Dermatitis (AD) Internet Survey
Using an Internet Survey to Improve Adherence in Pediatric Atopic Dermatitis
Status: Enrolling
Updated: 5/5/2016
Wake Forest University Health Sciences, Dermatology
979
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Treatment of Actinic Keratoses (AK) on the Face
An Investigator-Initiated Study to Assess the Efficacy and Degree of Irritation of Ingenol Mebutate 0.015% Gel and Dermasil Lotion Versus Ingenol Mebuate 0.015% Alone in the Treatment of Actinic Keratoses (AK) on the Face.
Status: Enrolling
Updated:  5/12/2016
mi
from
New York, NY
Treatment of Actinic Keratoses (AK) on the Face
An Investigator-Initiated Study to Assess the Efficacy and Degree of Irritation of Ingenol Mebutate 0.015% Gel and Dermasil Lotion Versus Ingenol Mebuate 0.015% Alone in the Treatment of Actinic Keratoses (AK) on the Face.
Status: Enrolling
Updated: 5/12/2016
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Actinic Keratosis Study
The Role of Calcipotriol in Treatment of Pre-cancerous Skin Lesions
Status: Enrolling
Updated:  5/18/2016
414
mi
from
Saint Louis, MO
Actinic Keratosis Study
The Role of Calcipotriol in Treatment of Pre-cancerous Skin Lesions
Status: Enrolling
Updated: 5/18/2016
Washington University School of Medicine
414
mi
from
Saint Louis, MO
Click here to add this to my saved trials
409
mi
from
Denver, CO
Clinical Research Facility
409
mi
from
Denver, CO
Click here to add this to my saved trials
1237
mi
from
Berlin, NJ
Clinical Research Facility
1237
mi
from
Berlin, NJ
Click here to add this to my saved trials